Leukaemia presents a significant medical challenge. Over the years, substantial advancements have been made in the field of leukaemia medicine, leading to the development of innovative and targeted treatments. These therapies aim to specifically combat the abnormal growth of leukaemia cells, offering hope for improved results and a better quality of life for patients. One notable breakthrough in leukaemia medicine is the introduction of blood cancer tablets.
These oral medications, often classified as targeted therapies, work by inhibiting specific molecular targets involved in the growth and survival of leukaemia cells. Blood cancer tablets have revolutionised treatment approaches, providing convenience and ease of administration for patients. Continue reading to learn some of the most blood cancer medicine names.
Leukaemia is a cancer affecting the blood and bone marrow. It includes the rapid production of abnormal white blood cells, which are responsible for fighting infections in the body. In this condition, the bone marrow produces excessive immature or malfunctioning white blood cells, crowding out the healthy cells and impairing their ability to perform their normal functions.
Leukaemia can be broadly classified into four main types:
Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukaemia (AML)
Chronic lymphocytic leukaemia (CLL)
Chronic myeloid leukaemia (CML)
The classification is based on the type of white blood cell affected (lymphoid or myeloid) and the progression of the disease (acute or chronic).
Leukaemia treatment options depend on the stage and type of the disease but may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. The goal of treatment is to destroy the leukaemia cells and achieve remission, allowing patients to live longer and healthier lives.
Medicine or drugs are crucial in Leukaemia treatment as it targets cancer cells, control disease progression, and improve patient outcomes. The specific role of leukaemia medicine depends on the type and stage of leukaemia and individual patient factors. Here are some key roles of medicine in leukaemia treatment:
Cause Remission: Medications, such as chemotherapy drugs or targeted therapies, are often used to induce remission in leukaemia. These treatments aim to reduce the number of cancer cells in the body and bring the disease under control.
Prevent Recurrence: After achieving remission, certain medications may be used to prevent the recurrence of leukaemia. These medications help to keep the disease in check and minimise the risk of relapse.
Target Specific Molecular Abnormalities: Some leukaemia medicines, such as tyrosine kinase inhibitors (TKIs) or monoclonal antibodies, target specific molecular abnormalities in cancer cells. By blocking the activity of these abnormal proteins or promoting immune responses, these medications help to inhibit leukaemia cell growth and promote their elimination.
There are several blood cancer tablets used for the treatment of leukaemia. One must remember that treatment decisions for leukaemia are highly individualised and depend on various factors such as the type and stage of leukaemia, genetic mutations, patient health, and response to therapy. Some common blood cancer tablet names include:
1. Imatinib: Imatinib is a special treatment for certain types of leukaemia, like chronic myeloid leukaemia (CML).
It works by stopping a protein called BCR-ABL, which is made by a changed gene in leukaemia cells.
By doing this, imatinib helps control the growth of leukaemia cells and improves the chances of remission.
The good thing is that imatinib mostly affects cancer cells, not healthy ones, which means fewer side effects.
The Foods and Drug Administration (FDA) approved imatinib as a treatment for patients with CML in 2001. Today, patients with CML in remission after two years of imatinib treatment have the same life expectancy as someone who does not have cancer.
Like any other medication, imatinib may cause certain side effects. Mild side effects may include:
Nausea and vomiting
Diarrhoea
Swelling in ankles, legs, arms, or face
Fatigue
Indigestion
Joint pain
Headache
Muscle cramps and pain
Dizziness
Common cold
Blurred vision
Hair loss
Other rare but serious side effects may include:
Severe fluid buildup around the heart and lungs and in the belly
Serious bleeding
Low level of red blood cells, platelets, or white blood cells
Liver problems
Heart problems
Kidney problems
Allergic reactions
Severe rash
Gastrointestinal problems, etc.
2. Dasatinib: Dasatinib is a special medicine used to treat certain types of leukaemia, like chronic myeloid leukaemia (CML).
It works by blocking a protein which is made by an abnormal gene in leukaemia cells.
By doing this, dasatinib helps control the growth of leukaemia cells and improves treatment effectiveness.
This chronic myeloid leukaemia medicine is taken orally, usually once a day, when other treatments are ineffective.
Dasatinib is designed to be more potent and effective than imatinib, particularly in cases where imatinib resistance has developed.
The medicine may cause some side effects, including:
Nausea or vomiting
Weakness
Headache
Diarrhoea
Mouth sores
Muscle, joint, or bone pain
Loss or appetite
Weight loss
Constipation
Stomach pain or swelling
Serious side effects requiring medical attention may include:
Fever, chills, sore throat, and other signs of infection
Shortness of breath
Chest pain or pressure
Coughing up bloody mucus
Swelling in hands, arms, feet, ankles, or lower legs
Irregular or rapid heartbeat
Fainting
Confusion
Vision changes, etc.
3. Nilotinib: Nilotinib is a type of targeted therapy that has shown success in treating chronic myeloid leukaemia (CML).
It works by targeting a protein which is made by a changed gene in leukaemia cells.
One of the advantages of this leukaemia medicine is that it can penetrate cells better than other medications, helping to stop the growth of leukaemia cells more effectively.
This has been shown to improve CML patients' response and remission rates.
Common or mild side effects of the medicine may include:
Nausea and vomiting
Headache
Fatigue
Skin rash
Dry skin
Cough
Common cold symptoms
Diarrhoea
Constipation
Pain in the joints or muscles
Other serious side effects of the medicine include:
Severe bleeding
Blockages in blood vessels or heart
Low levels of platelets, red blood cells, and white blood cells
Problems with electrolyte levels
Inflammation of the pancreas
Liver problems
Allergic reaction, etc.
4. Ponatinib: Ponatinib is a medicine used to treat specific types of leukaemia.
It is used when other treatments are ineffective, or cancer has become resistant.
This medicine targets multiple abnormal proteins, including the BCR-ABL protein, to help control leukaemia.
However, it is important to know that ponatinib can have serious side effects and is usually used as a last resort.
It is important to note that ponatinib is a potent medication typically used as a later-line therapy due to its potential for serious side effects.
Common side effects that usually resolve on their own include:
Nausea
Constipation
Dry skin
Muscle pain
Joint pain
Serious side effects that you must report to your healthcare provider include:
Seizures
Stroke
Fever, chills, sore throat, and other signs of infection
Liver injury
Increased blood pressure
Heart problems
Bleeding
Allergic reactions, etc.
5. Rituximab: Rituximab is a special medicine used for certain types of leukaemia, like chronic lymphocytic leukaemia (CLL) and some Non-Hodgkin lymphomas.
This medicine is a monoclonal antibody targeting a protein found on the surface of specific white blood cells called B-lymphocytes.
By targeting the specific protein present in the white blood cells, rituximab helps reduce the number of cancerous cells in the body, leading to better outcomes for leukaemia patients.
It is often used along with other medications to make the treatment more effective.
Common side effects of rituximab include:
Diarrhoea
Night sweats
Mouth sores
Back or joint pain
Feeling unusually anxious or worried
Serious side effects may include:
Fever, chills, or other signs of infection
Chest tightness
Unusual bruising or bleeding
Painful urination
Severe stomach pain or vomiting
Earache
Redness, tenderness, or swelling of the skin area
6. Blinatumomab: Blinatumomab is a special type of immunotherapy used to treat certain types of leukaemia.
It works by activating the body's immune system to fight cancer cells. Blinatumomab does this by bringing immune cells called T-cells close to the leukaemia cells and helping them destroy the cancer cells.
It specifically targets proteins in the leukaemia cells.
The treatment is given through a continuous intravenous infusion over a period of time.
Blinatumomab has shown to be effective, with high rates of complete remission, in patients with relapsed or refractory leukaemia, meaning the disease has come back or has not responded well to previous treatments.
The drug is also being investigated for its potential use in other types of leukaemia and lymphoma.
As with any medication, blinatumomab may have side effects, such as:
Diarrhoea
Constipation
Weight gain
Pain in the injection site
Back, joint, or muscle pain
Swelling in the arms, hands, feet, or lower legs
Other serious symptoms include:
Chest pain
Shortness of breath
Tingling or numbness in the arms, hands, feet, or legs
Fever, sore throat, cough, or other signs of infection
Pain that begins in the stomach and spreads to the back
7. Venetoclax: Venetoclax is a targeted therapy for certain types of leukaemia, like chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML).
It belongs to a group of drugs called BCL-2 inhibitors.
These drugs block a protein called BCL-2, which helps cancer cells survive and multiply.
By blocking BCL-2, venetoclax promotes the natural cell death process in leukaemia cells, helping to reduce their numbers and control the disease.
It is taken as a daily pill and has shown promising results when used alone or with other medications for CLL and AML.
Side effects of this leukaemia medicine include:
Nausea and vomiting
Diarrhoea
Constipation
Abdominal pain
Decreased appetite
Shortness of breath
Headache
Dizziness
Bone, muscle, or joint pain
Mouth or throat pain
Difficulty falling or staying asleep
Extreme tiredness, etc.
Other serious side effects may include:
Fever, sore throat, swollen skin, or other signs of infection
Swelling in the legs, ankles, or feet
Decreased urination
Unusual bleeding or bruising
Fast heartbeat
8. Cyclophosphamide: Cyclophosphamide is a chemotherapy drug used for different types of leukaemia, such as chronic myelogenous leukaemia, acute myeloid leukaemia, and acute lymphoblastic leukaemia.
It belongs to a class of drugs called alkylating agents.
One of the chemotherapy pills for leukaemia, cyclophosphamide, is often used together with other chemotherapy medications as part of a complete treatment plan.
This medication works by stopping or slowing down the growth of cells to treat leukaemia.
Common side effects may include:
Nausea and vomiting
Abdominal pain
Loss of appetite
Weight loss
Diarrhoea
Sores on the mouth or tongue
Hair loss
Skin colour changes
Serious side effects requiring medical attention may include:
Fever, chills, or other signs of infection
Unusual bruising or bleeding
Painful urination
Poor wound healing
Difficulty breathing
Chest pain
Itching
Swelling in the legs, ankles, or feet
Yellowing of the skin or eyes
9. Azacitidine: Azacitidine is a chemotherapy drug used to treat certain types of leukaemia, such as myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Azacitidine works by helping the bone marrow produce normal blood cells and killing abnormal cells in the bone marrow, ultimately reducing the growth and survival of leukaemia cells.
Azacitidine is typically administered through intravenous injection.
The treatment is given over several cycles, each consisting of daily or intermittent doses.
The side effects of these leukaemia injections include:
Nausea and vomiting
Constipation
Diarrhoea
Stomach pain
Loss of appetite and weight loss
Dizziness
Weakness
Headache
Excessive tiredness
Difficulty falling or staying asleep
Anxiety or depression
Night sweats
Muscle cramps
Difficulty urinating
Swelling in hands, ankles, feet, and lower legs
Dry skin, etc.
Serious side effects include:
Shortness of breath
Fast heartbeat
Chest pain
Unusual bleeding or bruising
Bleeding gums
Nosebleeds
Itching
Fever, chills, or other signs of infection
10. Midostaurin: Midostaurin is a targeted therapy used to treat certain types of leukaemia, specifically acute myeloid leukaemia (AML) and advanced systemic mastocytosis (a condition caused by the rapid growth of certain immune cells called mast cells).
It is classified as tyrosine kinase inhibitors (TKIs).
Midostaurin works by inhibiting multiple kinases, including FLT3, a mutated kinase often found in AML and mastocytosis.
By suppressing the activity of the mutated FLT3 kinase, this leukaemia medicine helps stop the spread of mast and cancer cells, reducing symptoms and progression of the disease.
Common side effects of midostaurin include:
Nausea and vomiting
Dizziness
Headache
Diarrhoea
Tiredness
Constipation
Stomach pain
Piles
Increased sweating
Swelling in the hands, ankles, feet, or lower legs
Difficulty falling or staying asleep, etc.
Other serious side effects include:
Fever, chills, or other signs of infection
Rapid or irregular heartbeat
Chest pain
Shortness of breath
Vomiting blood
Unusual bleeding or bruising
Pain when urinating
Itching
Swelling of the tongue, lips, or throat
While taking leukaemia medicine, it is important to follow certain precautions to ensure their safe and effective use. Although specific instructions may vary based on the type of leukaemia, treatment regimen, and individual patient characteristics, here are some general precautions to consider:
Follow the Prescribed Dosage: Take the medication exactly as your healthcare provider prescribes. Follow the recommended dosage, frequency, and duration of treatment. Do not alter the dosage or discontinue the medication without consulting your healthcare team.
Be Aware of Drug Interactions: Inform your healthcare team about any other medications, supplements, or herbal remedies you are taking. Certain medications can interact with leukaemia medicines, potentially affecting their efficacy or causing harmful side effects.
Remember the Timing: Some medications must be taken with food, while others require an empty stomach. Follow the specific instructions regarding timing and administration provided by your healthcare provider or written on the medication label.
Know the Side Effects: Familiarize yourself with the potential side effects associated with the medication. Monitor your body for adverse reactions and report them promptly to your healthcare provider. Some side effects may require medical attention or adjustment of the treatment plan.
Pregnancy and Contraception: Discuss the potential risks and appropriate contraceptive methods with your healthcare provider if you are of childbearing age or planning to conceive, as some leukaemia medications may have specific considerations during pregnancy.
Ensure Proper Storage: Follow the storage instructions provided by the manufacturer or your healthcare provider. Store these medicines in a cool, dry place, away from direct sunlight and out of the reach of children.
Adopting certain lifestyle changes can support overall well-being and complement medical treatments when managing leukaemia. Here are some lifestyle changes that may be beneficial:
Eat a Balanced Diet: Focus on consuming a nutritious, well-balanced diet rich in fruits, vegetables, healthy fats, lean proteins, and whole grains. Adequate nutrition helps support the immune system and maintain energy levels.
Stay Hydrated: Stay well-hydrated by drinking plenty of water throughout the day. Proper hydration helps with digestion and eliminating toxins.
Exercise Regularly: Engage in regular physical activity as your healthcare team permits. Exercise can help improve stamina, boost mood, maintain a healthy weight, and strengthen bones and muscles.
Manage Stress: Find ways to manage stress, like practising relaxation techniques, mindfulness, deep breathing exercises, or engaging in activities you enjoy. Stress reduction can support emotional well-being and help cope with the challenges of leukaemia.
Get Enough Sleep: Get sufficient rest and prioritise quality sleep. Adequate rest and sleep are essential for healing, managing fatigue, and maintaining overall well-being.
Prevent Infections: Take precautions to reduce the risk of infections, such as practising good hand hygiene, avoiding contact with sick people, and staying up-to-date with recommended vaccinations. Consult your healthcare team for additional infection prevention measures specific to your situation.
Quit Smoking and Limit Alcohol: If you smoke, consider quitting, as smoking can harm overall health and increase the risk of complications. Limit alcohol consumption or avoid it altogether, as alcohol can interfere with treatment.
Consulting a doctor after taking leukaemia medicine is important to ensure your treatment is on track and to address any complications that may arise. Here are some situations when it is recommended to seek medical advice:
Side Effects: If you experience any new or worsening side effects from the medication, it is essential to consult your doctor. These may include:
Severe allergic reactions
Persistent nausea or vomiting
Significant changes in appetite or weight
Unusual bleeding or bruising
Unexplained fatigue or weakness
Difficulty breathing
Any other concerning symptoms
Treatment Response: If you have concerns about the effectiveness of the medication or if you are not experiencing the expected improvement in your leukaemia symptoms or blood counts, it is important to discuss this with your doctor. They can evaluate your response to the treatment and make any necessary adjustments.
Leukaemia medicines are the warriors in the battle against this formidable disease, providing hope and healing to patients worldwide. From targeted therapies to immunotherapies, these medications are transforming the landscape of leukaemia treatment, improving survival rates and quality of life.
At HexaHealth, our dedicated team works tirelessly to ensure patients receive timely and affordable access to the top blood cancer tablets. With our comprehensive services and a patient-centric approach, we strive to support and empower leukaemia patients in their journey towards better health and brighter futures. Get in touch with a HexaHealth expert to know more! Together, we can overcome leukaemia and embrace a life full of hope and vitality.
Suggested Reads,
Leukaemia vs Lymphoma |
Bone Marrow Real Pictures |
Bone Marrow Cancer Symptoms |
Bone Marrow Function |
Bone Marrow Transplant |
Types Of Bone Marrow |
Leukaemia medicines, as part of targeted therapies and chemotherapy, work by inhibiting the growth and division of leukaemia cells, promoting cancer cell death, or suppressing the production of abnormal cells. These medications specifically target cancer cells while minimising harm to healthy cells.
Some of the commonly prescribed blood cancer tablets include imatinib (Gleevec), dasatinib (Sprycel), nilotinib (Tasigna), ponatinib (Iclusig), venetoclax (Venclexta), rituximab (Rituxan), and Blinatumomab (Blincyto). These medications are often used to treat various types of leukaemia and other blood cancers.
The choice of blood cancer tablets for children depends on the stage and type of blood cancer they are diagnosed with. Some commonly recommended tablets for pediatric blood cancers include vincristine, imatinib, methotrexate, mercaptopurine, and cyclophosphamide. However, the treatment plan is determined by the child’s oncologist based on individual factors and considerations.
There are several approved chemotherapy pills for leukaemia treatment. These medications are commonly prescribed based on the type and stage of leukaemia, individual patient factors, and treatment goals. Some examples include oral formulations of cytarabine, methotrexate, vincristine, and cyclophosphamide.
Yes, leukaemia injections can be an effective treatment option. Medications like rituximab are administered through injections. These injections allow for direct medication delivery into the bloodstream, ensuring efficient distribution throughout the body to target and eliminate leukaemia cells.
One of the most recommended immunotherapies for certain types of leukaemia, like acute lymphoblastic leukaemia (ALL) and chronic lymphocytic leukaemia (CLL), is chimeric antigen receptor (CAR) T-cell therapy.
This personalised treatment involves modifying a patient’s own T-cells to express specific receptors that target and kill leukaemia cells. Other common immunotherapies include monoclonal antibodies, donor lymphocyte infusion, and interferon.
Yes, there are emerging medications that show promise in treating leukaemia. For example, new targeted therapies like venetoclax have shown encouraging results in clinical trials for specific types of leukaemia.
Revumenib, a new targeted therapy, shows promising results for acute myeloid leukaemia (AML), one of the most difficult types to treat.
Several combination medications can be used for treating different types of leukaemia. Examples include:
Leukemia medicines can have side effects depending on the medication used. Common side effects may include fatigue, nausea, vomiting, diarrhoea, hair loss, decreased blood cell counts, increased risk of infections, and potential effects on the liver, kidney, or heart. It is important to discuss potential side effects with a healthcare provider.
Leukemia medicines should be taken as prescribed by a healthcare provider. They may be administered orally as tablets or capsules or through intravenous (IV) infusion as leukaemia injections. You must follow the prescribed dosage, schedule, and specific instructions the healthcare professional provides and promptly report any concerns or side effects.
The duration of treatment with the top leukaemia medicines can vary depending on the type and stage of leukaemia, individual patient factors, and treatment response. Treatment can range from a few months to several years. It is determined by the healthcare provider based on the specific circumstances of each patient’s case.
When taking the top 10 leukaemia medicine, following the prescribed dosage and schedule is important. Precautions may include regular monitoring of blood counts and other parameters, reporting any side effects promptly, avoiding certain medications or supplements that may interact with the leukaemia medication, and discussing any concerns or changes in health with a healthcare provider.
The availability and accessibility of the top 10 leukaemia medicines can vary depending on geographical location, healthcare system, and regulatory approvals.
These medications are typically available through prescription and can be obtained from hospitals, specialised cancer centres, or pharmacies. Access may also be influenced by insurance coverage and affordability considerations.
The cost-effectiveness of drugs used in leukaemia treatment can vary depending on the specific medication, healthcare system, and individual circumstances. While some leukaemia medications can be expensive, they may be considered cost-effective due to their efficacy and potential to improve patient outcomes. Factors like insurance coverage and assistance programs may also impact affordability for patients.
The effectiveness and success rates of the top 10 leukaemia medicines can vary depending on the specific medication, type of leukaemia, and individual patient factors. These medications have shown significant efficacy in inducing remission, improving survival rates, and managing the disease. However, the specific success rates can differ based on various factors and clinical circumstances.
Yes, there can be specific drug interactions to be aware of when taking the top 10 leukaemia medications. It is important to inform healthcare providers about all other medications, supplements, and herbal products being taken to check for potential interactions that may affect the effectiveness or safety of the leukaemia medicine.
Specific age restrictions for using the top 10 drugs in pediatric leukaemia patients may vary. Some drugs have age limitations or specific dosage adjustments, while others may be approved for use across different age groups. Consultation with a healthcare provider is necessary for accurate information.
The choice of recommended medicines for relapsed leukaemia cases depends on various factors, including the type of leukaemia, previous treatment history, and individual patient considerations. In such cases, healthcare providers may consider alternative targeted therapies, chemotherapy regimens, or stem cell transplant options tailored to the patient’s needs.
The expected response and remission rates of the top 10 leukaemia medicines can vary depending on the specific medication, type of leukaemia, and individual patient factors. These medications have shown significant efficacy in inducing remission and improving response rates, but the specific rates can differ based on various factors and clinical circumstances.
Last Updated on: 27 June 2023
HexaHealth Care Team brings you medical content covering many important conditions, procedures falling under different medical specialities. The content published is thoroughly reviewed by our panel of qualified doctors for its accuracy and relevance.